Cite
HARVARD Citation
Burton, K. et al. (2022). Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer. JCO precision oncology. p. . [Online].